ITM Isotope Technologies Munich SE

Dedicated to giving cancer patients better answers than "maybe"​.

General Information
Company Name
ITM Isotope Technologies Munich SE
Founded Year
2004
Location (Offices)
Germany +3
Founders / Decision Makers
Number of Employees
468
Industries
Biopharma, Biotechnology, Medical Devices +1
Funding Stage
Private Equity
Social Media

ITM Isotope Technologies Munich SE - Company Profile

ITM Isotope Technologies Munich SE is a biotechnology and radiopharmaceutical company founded in 2004, with a mission to provide targeted diagnostic and therapeutic radiopharmaceuticals and radioisotopes for cancer treatment. The company has established GMP manufacturing and a global supply network for medical radioisotopes, with a focus on developing a new generation of targeted cancer diagnostics and therapies. In June 2023, ITM secured a significant €255.00MPrivate Equity Round investment, with participation from BlackRock, Qatar Investment Authority, Temasek Holdings, Nextech Invest, Carbyne, and ATHOS. This investment underscores the confidence of leading global investors in ITM's innovative approach to precision oncology. The company's dedication to improving treatment outcomes and quality of life for cancer patients, along with reducing side effects and improving health economics, positions it as a key player in the biopharma, biotechnology, and pharmaceutical industries. Through a growing pipeline of targeted treatments in various stages of clinical development, ITM targets a range of cancers, including neuroendocrine tumors, glioblastoma, osteosarcoma, bone metastases, and folate receptor α positive tumors like lung, ovarian, and breast cancer. With a focus on precision and passion for innovation, ITM aims to provide cancer patients with better answers than "maybe." The company's commitment to advancing Targeted Radionuclide Therapies reflects its potential to contribute significantly to the field of oncology. For more information, visit www.itm-radiopharma.com. ITM's innovative approach, strong global collaborations, and recent investment underscore its potential as a key player in revolutionizing cancer treatment.

Taxonomy: radiopharmaceuticals, cancer treatment, precision oncology, therapeutic radiopharmaceuticals, radioisotopes, GMP manufacturing, targeted diagnostics, clinical development, neuroendocrine tumors, bone metastases, global supply network, health economics, theranostic radioisotope platform, strategic alliances

Funding Rounds & Investors of ITM Isotope Technologies Munich SE (0)

View All

There is no investment information

Latest News of ITM Isotope Technologies Munich SE

View All

No recent news or press coverage available for ITM Isotope Technologies Munich SE.

Similar Companies to ITM Isotope Technologies Munich SE

View All
Clarity Pharmaceuticals - Similar company to ITM Isotope Technologies Munich SE
Clarity Pharmaceuticals Clarity is developing next-generation products to address the growing need for radiopharmaceuticals in oncology.
OncoBeta - Similar company to ITM Isotope Technologies Munich SE
OncoBeta Painless, Non-Invasive, Non-Melanocytic Skin Cancer Therapy
Brenus Pharma - Similar company to ITM Isotope Technologies Munich SE
Brenus Pharma Next-generation cancer treatment bringing the immune system one step ahead of cancer 🧬🟣
Notable - Similar company to ITM Isotope Technologies Munich SE
Notable Notable is a mission-driven company transforming the way cancer is treated